Generation of an induced pluripotent stem cell line from a long QT syndrome patient carrying KCNH2/1956C > A mutation

Generation of an induced pluripotent stem cell line from a long QT syndrome patient carrying KCNH2/1956C > A mutation

Long QT syndrome (LQT) is an inherited primary arrhythmic disorder characterized by prolonged QT interval on the surface electrocardiogram and life-threatening arrhythmia. In this study, a skin biopsy was obtained from an LQT type 2 (LQT2) patient, who carried a nonsense mutation (c.1956C > A; p....

Full description

Bibliographic Details
Main Authors:	Fengfeng Guo, Yaxun Sun, Hongkun Wang, Hao Wang, Jingjun Zhou, Hangping Fan, Jun Su, Tingyu Gong, Chenyang Jiang, Ping Liang
Format:	Article
Language:	English
Published:	Elsevier 2022-07-01
Series:	Stem Cell Research
Online Access:	http://www.sciencedirect.com/science/article/pii/S1873506122001623

Similar Items

Generation of an induced pluripotent stem cell line (ZJULLi003-A) from a hypertrophic cardiomyopathy patient carrying MYH7/c.4384G > A mutation
by: Jingjun Zhou, et al.
Published: (2022-10-01)

Establishment of an induced pluripotent stem cell line (ZJULLi004-A) from a hypertrophic cardiomyopathy patient carrying MYBPC3/c.3764C>A mutation
by: Yaxun Sun, et al.
Published: (2022-10-01)

Generation of KCNH2 heterozygous knockout induced pluripotent stem cell (iPSC) line (Long and Short QT Syndrome)
by: Baiqiang Wang, et al.
Published: (2024-06-01)

Generation of three heterozygous KCNH2 mutation-carrying human induced pluripotent stem cell lines for modeling LQT2 syndrome
by: Gema Mondéjar-Parreño, et al.
Published: (2021-07-01)

Generation of a human embryonic stem cell line (WAe009-A-43) carrying a Long QT syndrome related mutation in KCNH2 gene
by: Xiaodan Wu, et al.
Published: (2020-10-01)

Establishment of human embryonic stem cell WAe009-A-74 carrying a Long QT syndrome mutation in KCNH2
by: Lixiang Sun, et al.
Published: (2022-04-01)

Establishment of human embryonic stem cell WAe009-A-88 carrying a long QT syndrome mutation in KCNH2
by: Hong Wen, et al.
Published: (2022-07-01)

The lack of effect of sotalol in short QT syndrome patients carrying the T618I mutation in the KCNH2 gene
by: Carla Giustetto, MD, et al.
Published: (2015-09-01)

Generation of an induced pluripotent stem cell line from the dermal fibroblasts of a patient with arrhythmogenic right ventricular cardiomyopathy carrying a PKP2/c.2489 + 1G > A mutation
by: Danni Zhou, et al.
Published: (2020-10-01)

Overexpression of KCNJ2 enhances maturation of human-induced pluripotent stem cell-derived cardiomyocytes
by: Jingjun Zhou, et al.
Published: (2023-04-01)

Generation of patient-specific induced pluripotent stem cell lines with Type 2 Long QT Syndrome and the KCNH2 c.379C > T pathogenic variant
by: Lamia Goual, et al.
Published: (2023-10-01)

Identification and characterization of two novel KCNH2 mutations contributing to long QT syndrome.
by: Anthony Owusu-Mensah, et al.
Published: (2024-01-01)

Generation of induced pluripotent stem cells (iPSCs) from a Chinese infant (XACHi015-A) with type 2 Long QT syndrome carrying the heterozygous mutation c.1814C>T(p.P605L) in KCNH2
by: Tao Wang, et al.
Published: (2021-10-01)

Mexiletine shortens the QT interval in a pedigree of KCNH2 related long QT syndrome
by: Taishi Fujisawa, et al.
Published: (2020-02-01)

Generation of an induced pluripotent stem cell line from a patient carrying FBN1/c.6734 G > A mutation
by: Ziwei Pan, et al.
Published: (2021-08-01)

Human induced pluripotent stem cell line ZZUNEUi027-A generated from a long QT syndrome patient with a heterozygous KCNH2 (c. 128 A > G) mutant
by: Jiangtao Zhao, et al.
Published: (2022-08-01)

Trafficking defect and proteasomal degradation contribute to the phenotype of a novel KCNH2 long QT syndrome mutation.
by: Anton Mihic, et al.
Published: (2011-03-01)

Computational analysis of arrhythmogenesis in KCNH2 T618I mutation-associated short QT syndrome and the pharmacological effects of quinidine and sotalol
by: Shugang Zhang, et al.
Published: (2022-11-01)

Long QT syndrome and left ventricular non-compaction in a family with KCNH2 mutation: A case report
by: Thomas Caiffa, et al.
Published: (2022-08-01)

Characterization of the molecular mechanisms underlying azithromycin‐induced cardiotoxicity using human‐induced pluripotent stem cell‐derived cardiomyocytes
by: Xiaochen Wang, et al.
Published: (2021-09-01)

Family long QT syndrome type 2 associated with <em>KCNH2</em> gene mutation: aborted sudden cardiac death
by: Iván Alejandro Elizalde Uribe, et al.
Published: (2023-09-01)

Clinical Feature, Treatment, and KCNH5 Mutations in Epilepsy
by: Xiufu Hu, et al.
Published: (2022-07-01)

Generation of a human embryonic stem cell line WAe009-A-79 carrying a long QT syndrome mutation in KCNQ1
by: Hongyue Wang, et al.
Published: (2023-08-01)

A Novel <i>KCNH2</i> S981fs Mutation Identified by Whole-Exome Sequencing Is Associated with Type 2 Long QT Syndrome
by: Yu-Wen Cheng, et al.
Published: (2023-08-01)

Protective effect of <it>KCNH2 </it>single nucleotide polymorphism K897T in LQTS families and identification of novel <it>KCNQ1 </it>and <it>KCNH2 </it>mutations
by: Oberti Carlos, et al.
Published: (2008-09-01)

Generation of two induced pluripotent stem cell lines from dilated cardiomyopathy patients carrying TTN mutations
by: Tina Tianbo Zhang, et al.
Published: (2022-12-01)

Novel <i>KCNH1</i> Mutations Associated with Epilepsy: Broadening the Phenotypic Spectrum of <i>KCNH1</i>-Associated Diseases
by: Randi von Wrede, et al.
Published: (2021-01-01)

Generation of two induced pluripotent stem cell lines from dilated cardiomyopathy patients carrying heterozygous FLNC mutations
by: Ana Kojic, et al.
Published: (2022-10-01)

Generation of human induced pluripotent stem cell lines carrying heterozygous PLN mutation from dilated cardiomyopathy patients
by: Arianne Caudal, et al.
Published: (2022-08-01)

Generation of eight human induced pluripotent stem cell lines from Parkinson's disease patients carrying familial mutations
by: Muwan Chen, et al.
Published: (2020-01-01)

Generation of three induced pluripotent stem cell lines from hypertrophic cardiomyopathy patients carrying MYH7 mutations
by: Xu Cao, et al.
Published: (2021-08-01)

Establishment of induced pluripotent stem cell line (ZZUi010-A) from an Alzheimer's disease patient carrying an APP gene mutation
by: Zhilei Wang, et al.
Published: (2017-12-01)

Corrigendum to “Reprogramming of human peripheral blood mononuclear cells from a patient suffering from recurrent hydatidiform mole to an iPSC line FAHZUi001-A carrying a homozygous p.Gln421Ter mutation in NLRP7 gene” [Stem Cell Res. 53 (2021) 102361]
by: Tingyu Gong, et al.
Published: (2021-08-01)

Identification of a novel pathogenic variant in KCNH2 in an Iranian family with long QT syndrome 2 by whole‐exome sequencing
by: Amir Farjam Fazelifar, et al.
Published: (2023-06-01)

Discovery of Digenic Mutation, KCNH2 c.1898A >C and JUP c.916dupA, in a Chinese Family with Long QT Syndrome via Whole-Exome Sequencing
by: Yafei Zhai, et al.
Published: (2020-06-01)

Generation of two induced pluripotent stem cell lines from patients with cardiac amyloidosis carrying heterozygous transthyretin (TTR) mutation
by: Bernardo Bonilauri, et al.
Published: (2023-10-01)

Generation of two induced pluripotent stem cell lines carrying the phospholamban R14del mutation for modeling ARVD/C
by: Carlos D. Vera, et al.
Published: (2022-08-01)

Generation of an induced pluripotent stem cell line from a patient with Angelman syndrome carrying UBE3A mutation
by: Shasha Li, et al.
Published: (2022-07-01)

Generation of an induced pluripotent stem cell line from a patient with surfactant metabolism dysfunction carrying ABCA3 mutations
by: Xiaojuan Yin, et al.
Published: (2021-05-01)

Generation of a human induced pluripotent stem cell line from an epilepsy patient carrying mutations in the PIK3R2 gene
by: Bei Zhang, et al.
Published: (2020-04-01)